HUDDINGE, Sweden, Nov. 10, 2023 /PRNewswire/ — XNK Therapeutics AB (“XNK”) today announced that Johan Liwing, CEO, will present the company at the at Investival Showcase Meeting in London, on November 13th The LSX Investival Showcase meeting is one of Europe’s biggest pitch events for…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.